Ribonucleotide reductase subunit M2 can be new molecular target and prognostic biomarker of hepatocellular carcinoma

Gut Liver. 2014 Nov;8(6):580-1. doi: 10.5009/gnl14377.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Hepatocellular / metabolism*
  • Female
  • Humans
  • Liver Neoplasms / metabolism*
  • Male
  • Neoplasm Recurrence, Local / metabolism*
  • Ribonucleoside Diphosphate Reductase / metabolism*

Substances

  • Biomarkers, Tumor
  • Ribonucleoside Diphosphate Reductase